GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹484 Cr | ₹811 Cr | ₹578 Cr | ₹490 Cr | ₹409 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹484 Cr |
Mar2022 | ₹811 Cr |
Mar2021 | ₹578 Cr |
Mar2020 | ₹490 Cr |
Mar2019 | ₹409 Cr |
How is Cash Flow from Operating Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹484 Cr | -40.27 | |
Mar2022 | ₹811 Cr | 40.29 | |
Mar2021 | ₹578 Cr | 17.82 | |
Mar2020 | ₹490 Cr | 19.78 | |
Mar2019 | ₹409 Cr | - |
Compare Cash Flow from Operating Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹36,128.8 Cr | 9.5% | 8.6% | 64.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 9.5% |
8.6% |
64.8% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses